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In the present study, we examined the effect of ethanolic soluble derivative of propolis (EEP) extract on immunological
function in diabetic mouse models with the aim of highlighting the role of regulatory T cell, the change of cell surface
molecule, and in vivo productions of IFN-γ. Murine models of diabetes mellitus (DM) were created by injecting normal
mice with S961 peptide. Normal BALB/c mice were injected intraperitoneally with peptide S961 300 mg/kg body
weight (BW) twice a day for eight days. On day 15, the spleen was isolated; then, cell surface molecules and regulatory
T cells were analyzed using flow cytometry. The histopathological changes were monitored in the liver of treated and
control mice. Afterward, we tested the ability of propolis as an immunomodulator that initiate normality metabolism
and homeostasis. The propolis decreased blood sugar levels and increased the number of naïve T cells expressing
CD62L molecule by suppressing the development of effector cells in diabetic mice. However, the propolis stimulated
development of effector cells, which was indicated by increasing the number of CD4+CD25+ T cells in normal mice.
Moreover, the propolis increased the production of IFN-γ in normal mice, whereas in mouse models of diabetes mellitus
propolis tends to suppress the production of IFN-γ. The histological analysis of the liver shows that at a dose of 50–200
mg/kg BW propolis does not show a toxic effect so that the dose is categorized safe. Therefore, the ethanolic soluble
derivative of propolis (EEP) extract warrant for further exploited as an antidiabetic agent that safe for human.
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Diabetes mellitus is the worst and fastest growing meta-
bolic disorder in the world. Now it is known that the
heterogeneity of this disorder also increases so that an
appropriate therapy becomes a significant challenge.
Severe metabolic imbalances and non-physiologic changes
in many tissues can occur in diabetes, where oxidative
stress plays a critical role in the etiology. Reactive oxygen
species (ROS) is involved in diabetes, and it contributes
oxidative damage, particularly to nerve, liver, heart, kidney,
eyes, large and small blood vessels and immunological sys-
tem (Oršolić and Bašić 2008; Yue et al. 2003; Obrosova
et al. 2003; Loprinzi et al. 2014).
Diabetes mellitus is currently stretching across the
entire world. It penetrates population not only in poor
and developing countries, but also in developed ones.* Correspondence: rifa123@ub.ac.id
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In every ten seconds, one person dies from diabetes
mellitus. Indonesia is one country having the greatest
biological biodiversity in the world. It has natural resources
that potentially increase the population welfare as well
as provide a wide range of materials to cure various
diseases (Vikram and Jena 2010; Syamsudin et al. 2008;
Kusumawardani 2011; Castaldo and Capasso 2002). So
far, the treatment of various diseases including type-2
diabetes mellitus has a dependency on the synthetic drugs
whose safety is still being debated. On the other hand, a
lot of herbal medicines claimed to relieve and even to cure
type 2 diabetes mellitus. Unfortunately, most of traditional
medicine society claimed the various herb treatments have
an efficacy without scientific evidence. By considering the
case of diabetes mellitus, particularly type-2 diabetes that
continues to grow, it is necessary to do adequate research
to find a useful drug to ameliorate or even to cure the
disease (Murata et al. 2004; Khalil 2006; McLennan et al.is is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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Sartori et al. 2009).
There has been a growing public opinion arguing that
propolis can cure diabetes mellitus. Propolis is complex
resinous material collected by honey bees from buds and
exudates of certain plant sources neighbouring their
hives. The main types of flavonoids contained in propolis
are pinocebrin, galangin, chrisin, and caffeic acid phenethyl
ester. The use of propolis as an alternative healing therapy
for type-2 diabetes mellitus has been claimed to alleviate
the disease. Previous study states that propolis improves
normal homeostasis by balancing the body’s condition
through the enhancement of the immune system (Oršolić
and Bašić 2008; Yue et al. 2003; Obrosova et al. 2003;
Loprinzi et al. 2014; Ganong 2005; Mahler dan Adler 1999;
Cetin et al. 2010; Arora et al. 2009; Bailey 1999; Kang et al.
2010; Sforcin 2007). However, the mechanism action of
propolis to modulate the immune system to face type-2
diabetes mellitus cannot be explained. Water extracts of
propolis have been studied to prevent the destruction of
beta cells by inhibiting the activation of IL-1β and NO
synthase activity. Administration with water or ethanolic
extract of propolis for seven weeks in mice can decrease
glucose, triglyceride, and total cholesterol levels in the
blood, thus it is alleged that propolis can control glucose
levels and modulate glucose and lipid metabolism. Prop-
olis is also alleged to decline the lipid peroxidation output,
and to function as a scavenger for free radicals in rat
models of diabetes mellitus. Propolis possesses many
functions of biological activities and also has used in
folk medicine. Administration of propolis to mouse models
of DM suggests homeostasis maintenance, so that further
activated cell can be controlled by involving regulatory T
cells from both CD4 and CD8 T cells (Oršolić and Bašić
2008; Yue et al. 2003; Obrosova et al. 2003; Sforcin and
Bankova 2011; Sawicka et al. 2012; Rifa’i et al. 2004; Lee
et al. 2008).
CD4+CD25+ regulatory T cells (Treg) are of central
importance for the immune tolerance network and,
malfunction of this T cell population can either lead to
impaired or increased suppression apparently resulting
in an array of distinct diseases. The role of CD4+CD25+
regulatory T cells in diabetes mellitus is still being
debated. These cells are reported to produce IL-10, TGF-
β, and IL-4 to stop T cells activation. Some investigators
reported that activation and proliferation of Treg correlate
with their ability to suppress diabetes, suggesting that
existence of Treg is important to maintain homeostasis
(Bluestone and Tang 2005; Mahmoud and Al-Ozairi 2013;
Afzal et al. 2014). However, another investigator state that
Treg was not involved in the development of diabetes
mellitus (Afzal et al. 2014). In peripheral blood of DM
patient showed a significant increase of IFN-γ, TNF-α,
and IL-8. These cytokines contribute to aggravate DMpatient and in early stage also cause in the development
of insulin resistance (Mahmoud and Al-Ozairi 2013;
Aoi et al. 2013). In the other hand propolis is known to
contain high-level nutrient factor including vitamins,
polyphenols, and amino acids that would be expected
to improve insulin sensitivity. Thus, intake of propolis
to decline the expression of inflammatory molecules is
one of strategies to ameliorate patient with hyperglycemia.
The present study was designed to investigate the effect of
ethanolic soluble derivative of propolis extract on T cell
activation, blood glucose uptake, apoptosis of splenic cell,
regulatory T cell development, and IFN-γ production.
Results and discussion
S961 peptide had an ability to bind with insulin receptor
or insulin receptor antagonist. Giving S961 peptide for
eight consecutive days might increase blood sugar levels.
It was caused by the loss of insulin receptor function
blocked by S961. The loss of insulin receptor function
would lead to hyperglycemia and also hyper-insulinemia
(Vikram and Jena 2010). The increase of blood sugar
levels had been seen since two days after the injection
of S961 peptide. A high level of blood sugar would be
more stable six days after injection of S961 peptide.
DM mice treated daily with propolis at doses of 50,
100, or 200 mg/kg BW showed a decrease in blood
sugar levels (Figure 1). At doses of 100 to 200 mg/kg
BW showed a decrease in blood sugar levels significantly
(P < 0.05) compared to controls. The reduction blood
sugar levels after treatment with propolis showed that
cells were able to metabolize sugar even though insulin
receptor was blocked. Although mechanism of action
by which propolis can reduce blood glucose level is still
illusive, but some investigators suggest that propolis
improve glucose uptake by increasing pH of ascites and
metabolic tissues (Aoi et al. 2013; McCarty 2005; Cameron
et al. 2006; Maalouf et al. 2007; Hayata et al. 2014). In
general, diabetes patients have body fluid with acidic
condition due to elevation of ketone body production, and
improvement of pH can ameliorate healthy condition
(Hayata et al. 2014; Cameron et al. 2006; Maalouf et al.
2007; McCarty 2005; Marunaka et al. 2014). Therefore, we
speculated that the declined level of blood glucose could
be caused by increasing insulin receptor sensitivity due to
increasing pH. Moreover according to Aoi et al. (2013)
dietary propolis elevated buffering capacity in tissue or
suppress the production of organic acid so that propolis
may improve insulin sensitivity by preventing metabolic
acidosis.
Administration of propolis in normal mice induced T
cell activation. Normal mice receiving propolis with a
dose of 200 mg/kg BW showed an increase activated T
cells, CD8+CD62L-. Figure 2 showed that naïve T cells
in control was 60.82% whereas the number changed
Figure 1 Propolis could decrease blood sugar levels. Mouse models of diabetes mellitus (DM) were orally administered by propolis. It was
given once a day at doses of 50, 100, or 200 mg/kg BW indicated in the picture. Blood sugar level was measured every other day, and the figure
above reported the mean for seven blood measurements.
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200 mg/kg BW. There were several possibilities that
cause naïve T cells shift onto memory types. First, propolis
was suspected able to trigger T cell proliferation and
activation so that the cell lost CD62L molecules. Second,
propolis might stimulate T cells to produce cytokines and
such activated T cells lost their CD62L molecule. Interest-
ingly in DM mice, propolis could increase the number of
naïve T cells. As shown in Figure 2, naïve T cells changed
from 23.50% to 28% after receiving propolis. It was
suggested that propolis prevented further activation inFigure 2 Propolis in normal mice promote T cell activation but in mo
Normal mice as a negative control. B) Normal mice treated by propolis at d
a positive control. D) DM mice treated by propolis at dose of 200 mg/kg Border to reach better homeostasis in DM mice. In general,
activated T cells will lose CD62L molecules and increase
the expression of CD44 and CD69 molecules. CD69 is
a cell surface protein synthesized rapidly about two
hours after the activation. In diabetic patients, T cell
activation can be triggered by the recognition of self-
antigen by cytotoxic T and Th1 T cells. T cell activation in
turn triggers the activation of other cells involved in
the immune system resulting in systemic homeostasis
disorders (Rifa’i et al. 2004, 2008; Lee et al. 2008; Shi
et al. 2009).use models of DM it prevented further cell activation. A)
ose of 200 mg/kg BW. C) Mouse models of diabetes mellitus (DM) as
W.
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observed the degree of apoptotic cells in the lymphocyte
population. The data showed that the number of T cells
undergoing apoptosis in the healthy mice treated by
propolis was increased. The increasing of apoptosis cells
was alleged to offset the high proliferation activity in
order kept in balance of the total number of T cells. The
opposite phenomenon occurred in DM mouse models.
In DM mice, spleen cells had a higher rate of apoptosis
compared to healthy mice (Figure 3). It was thus quite
plausible that in vivo environment of DM mice had a
situation to force spleen cells undergoing apoptosis. The
apoptosis suggested to prevent further damage caused
by activated T cells. Further, analysis showed that admin-
istration of propolis in DM mice was known to decrease
the rate of apoptosis. This result relates to the evidence
that propolis can prevent excessive cell activation. As we
have already explained above, after the addition of prop-
olis, T cell surface molecule of lymphocyte is dominated
by CD62L (Figure 2) (Rifa’i et al. 2004; Lee et al. 2008).
Regulatory T cells, CD4+CD25+ T, have a crucial role
both in infectious and degenerative diseases. In many
cases, CD4+CD25+ T cells have impotent roles to maintain
normal homeostasis. However, the role of regulatory T
cells in diabetes mellitus is still unclear. To investigate the
role of regulatory T cells in diabetes mellitus in this study
we examined the expression of CD25 molecules on CD4
T cells. In the present study, we found that the intake of
propolis increase the number of CD4+CD25+ T cellsFigure 3 In normal mice, propolis triggered apoptosis in spleen cells
A) Normal mice as a negative control. B) Normal mice treated by propolis
as a positive control. D) DM mice treated by propolis at dose of 200 mg/kgcompared with control, suggesting that dietary propolis
promote T cell activation and proliferation (Figure 4).
Therefore, we could not explain whether the CD25 mol-
ecule expressed on CD4 T cells was the sign of increase in
regulatory T cells. According to Rifa’i et al. (2004) and Rifa’i
(2010), the emergence of CD25 molecules can occur if cells
are activated and proliferate. CD25 molecule is IL-2Rα
which will be synthesized by proliferating cells. Proliferating
cells utilize IL-2, so that the presence of IL-2 receptor is
required for the cells that are being actively proliferated.
Thus, the presence of CD25 molecules does not necessarily
indicate an increase in regulatory T cells. However, the
emergence of CD25 molecules remains a very interesting
phenomenon because in general CD25 molecule can be
used as a marker of regulatory T cells even though another
marker such as FOXP3 should be included (Shi et al. 2008,
2009; Rifai’i 2010; Lee and Rifa’i 2011).
It is very interesting that the CD4+CD25+ T cells were
increased in the mouse model of diabetes mellitus. There
are some possibilities why CD4+CD25+ T cells increase in
the mouse model of diabetes mellitus. First, an increase of
CD4+CD25+ T cells is a manifestation of regulatory T cell
enhancement to prevent further cell activation. This fact
is consistent with the data shown by Figure 1 in which T
cells in mice model of diabetes mellitus were dominated
by lymphocytes that lose CD62L molecule, so that the
suppressor cells were required to overcome the activated
cells. Second, the increase in T cells with CD4+CD25+
marker may be due to the cells being activated andbut in mouse models of diabetes mellitus it prevented apoptosis.
at dose of 200 mg/kg BW. C) Mouse models of diabetes mellitus (DM)
BW.
Figure 4 CD4+CD25+ T cells increased in normal mice that received propolis and vice versa they reduced in mouse models of DM.
A) Normal mice as a negative control. B) Normal mice treated by propolis at dose of 200 mg/kg BW. C) Mouse models of diabetes mellitus
(DM) as a positive control. D) DM mice treated by propolis at dose of 200 mg/kg BW.
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IL-2. Between the two possibilities above, the second pos-
sibility may be closer to the truth. This idea is sup-
ported by evidence that administering propolis to mice
model of diabetes mellitus decreases the expression of
CD25 molecules. This fact is consistent with data in
Figure 2 showing that the administration of propolis
led to naïve cells (CD62L) were more dominant. The
domination of naïve cells reflects that the homeostasis
in an individual is running well so that mature T cells
migrating from thymus to peripheral lymphoid tissue
are not activated. The reduction of activated T cells in
DM mice after receiving propolis is corresponding with
rules of physiological framework. The activated cells will
undergo apoptosis when the cells are no longer needed
(Rifai’i 2010; Lee and Rifa’i 2011).
In normal mice, the administration of propolis increased
the expression of interferon gamma (IFN-γ). In contrast,
mouse models of DM did not show an increase in IFN-γ
production when propolis was administered (Figure 5).
The phenomenon why mice model of DM resistant to
propolis could not be described in this experiment. There
was a possibility that blocking insulin receptor with S961
peptide contribute to this phenomenon (Vikram and Jena
2010). In certain stages IFN-γ was indispensable for the
body’s defense system, primarily to cope viral replication
and increased the expression of MHC class I and II (Rifa’i
et al. 2004). It could thus be expected that the increase ofIFN-γ in normal mice after receiving propolis would
strengthen their immune system. Slight increase of IFN-γ
production in normal mice after administering propolis
did not bother normal homeostasis but rather improved
the quality of the immune system. However, we presume
that propolis acts as a medicinal agent without involving
the role of IFN-γ directly (Nakamura et al. 2011).
Conclusion
Administration of Ethanolic soluble derivative of propolis
(EEP) extract to diabetic mice able to decrease of blood
sugar levels, suppress the development of effector cells
and production of IFN-γ. The propolis also does not show
a toxic at a dose of 50–200 mg/kg BW that warrant for an
antidiabetic agent that safe for human.
Materials and methods
Mice
In this study we used 8-weeks-old BALB /c, which were
maintained in the pathogen free facility, Biology Department,
Faculty of Sciences, Brawijaya University, Malang, Indonesia.
Preparation of ethanol extract of propolis
Propolis was obtained from Lawang, East Java, Indonesia.
GC-MS analysis has shown that Ethanolic propolis extract
(EEP) contained (percentage of total ion current): Benzoic
acid 0.41, Phenylic acid 95.62, D-glucofuranuronic acid
0.56, 4-oxo-2-thioxo-3-thiozolidinepropionic acid 0.79, 1-
Figure 5 Administration of propolis in normal mice increased the expression of IFN-γ, but not in mouse models of DM. A) Normal mice
as a negative control. B) Normal mice treated by propolis at dose of 200 mg/kg BW. C) Mouse models of diabetes mellitus (DM) as a positive
control. D) DM mice treated by propolis at dose of 200 mg/kg BW.
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0.51, Threitol 0.86, Glycerol 0.86 (Syamsudin et al. 2009).
Preparations of propolis extract consisted of three phases
including drying, extracting, and evaporating. The drying
process began by washing the sample, cutting it into small
pieces, and putting them in the oven with a temperature
of 40–60°C. Before the extraction process, samples were
dried and then crushed by a blender. 100 grams of dry
samples were weighed and put in 1 L Erlenmeyer glass,
soaked with ethanol to the volume of 1 L. Sample in etha-
nol was stirred for ± 30 minutes and allowed to stand
overnight to settle. Then, solution containing the active
substance was filtered with filter paper. Soaking process
was repeated three times and the last stage was evapor-
ation. Extraction solvent was inserted into 1 L evaporation
flask. Then, water bath was filled with water up to a full cir-
cuit and then installed according to an equipment protocol
and set to a temperature of 90°C. Ethanol was allowed to
drip in the flask (±1.5–2 hours/flask containing ± 900 mL).
Extraction results obtained roughly one tenth of dried
natural materials (ten grams extract/100 gram’s sample).
Induction of type 2 diabetes mellitus with peptide S961
and propolis treatment
Normal BALB/c mice were injected intraperitoneally with
peptide S961 300 mg/kg BW twice a day for eight days.
Mice were divided into five groups including positive and
negative control groups. The dose of propolis each 50,
100, and 200 mg/kg respectively was administered by oralgavage to BALB/c mice once a day from the first day of
peptide injection until the day 14. Glucose level was mea-
sured every other day. On day 15, the spleen was isolated,
then cell surface molecules, intracellular cytokine, and
regulatory T cells were analyzed by flow cytometry.
Oral treatment with dextrose and sucrose
Mouse models of diabetes mellitus received dextrose (2 g/
kg BW) by force-fed to maximize diabetes condition. 150
grams of pure sugar/sucrose were put into the Erlenmeyer
flask added with 1350 mL of distilled water and shaken to
homogenize the solution. Sucrose solution was given to
groups of mouse models of diabetes mellitus as they had
ad libitum drinking. Sucrose solution was given simultan-
eously with the injection of peptide and replacement of
sucrose solution was performed daily for two weeks.
Measurement of blood sugar levels
Measurement of blood sugar level was done every other
day with One Touch Glucometer. Mice were put into a
trap, and the blood was taken from their tails. Blood was
dropped into a glucostick screen installed on glucometer
and noted within 5 seconds.
Isolation of lymphoid cells and flow cytometry analysis
Spleen was washed with sterile PBS twice and put on
petri dish containing sterile PBS. Spleen organ was pressed
by using syringe holder. Single cell solution was filtered
with a sterile wire and put into a 15 mL polypropylene.
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10 mL and then put in a centrifuge (2500 rpm, 4°C for five
minutes). Then the supernatant was discarded, and the
obtained pellet was resuspended with 1 mL of sterile PBS.
Single cell suspension containing 2 ~ 3 × 106 cells was
washed with PBS and stained with FITC-conjugated
anti-mouse CD4, PE-conjugated anti-mouse CD8, PE-
conjugated anti-mouse CD25, PE-conjugated anti-mouse
CD62L and anti- mouse CD62L (Rifa’i et al. 2004;
Bluestone and Tang 2005).
Intracellular staining
Intracellular cytokine staining was performed with a Cyto-
fix/Cytoperm kit (BD-Biosciences Pharmingen) according
to the protocol provided by the manufacturer. Cells
were incubated with FITC-conjugated anti-mouse CD4,
PE-conjugated anti-mouse CD8, PE-Cy5-conjugated anti-
mouse anti-interferon (IFN)-γ antibodies. Pellets with
approximately 2 ~ 3 × 106 cells were stained with FITC-
conjugated anti-mouse CD4, PE-conjugated anti-mouse
CD8 for 30 minutes. After incubation, the suspension was
washed, and pellet was resuspended in cytofix buffer
(200 μL) for 20 minutes in dark conditions, 4°C, then resus-
pended in 1 mL wash-perm and centrifuged again at
2500 rpm at 4°C for 5 minutes. Supernatant was discarded,
and the obtained pellet was subjected to intracellular stain-
ing with anti-mouse anti-interferon (IFN)-γ for 30 minutes.
Examination of apoptotic cells
Double staining for cellular DNA using propidium
iodide (PI) and FITC- conjugated annexin V binding
was performed as follows. After washing twice with
PBS, 2 ~ 3 × 106 cells were resuspended in annexin-V
binding buffer and FITC-conjugated annexin-V was
added to a final concentration of 1 μg/mL cell suspen-
sion. PI (10 μg/mL in annexin-V binding buffer) was
added 15 minutes before running in Flow Cytometry.
PI concentration was adjusted in a final concentration of
1 μg PI/mL cell suspension. The mixture was incubated
for 15 minutes in the dark at room temperature and then
analyzed with Flow Cytometry (Caliber using CellQuest
program).
Statistical analysis
The obtained data were analyzed by CellQuest software
and tested by statistical analysis ANOVA (Analysis of
Variance) with P < 0.05. All results were presented as
mean of ± SD values of five mice in each group.
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